Piramal Pharma Limited — Others, 26-06-2025: Disclosure under SEBI Takeover Regulations

Piramal Pharma’s Promoter Group has confirmed they have not created any encumbrance on the company’s shares or securities during the current financial year. This assures investors of the promoters’ commitment and absence of any pledge or charge on their holdings, reflecting financial stability and confidence in the company’s prospects.